This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Otolaryngology/ Head & Neck Surgery, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Jonas T. Johnson, MD

Arch Otolaryngol Head Neck Surg. 2005;131(7):549-550.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

Twenty years have gone by since the first International Conference on Head and Neck Cancer. We have seen some significant changes. Modern technology has vastly expanded our diagnostic and therapeutic armamentarium. With these innovations come many new opportunities and obligations. Today, I will speak not so much about the opportunities but about the obligations we have to our patients and to ourselves to maximize the benefits available now and in the future on behalf of our patients.

Never before have we been so dependent on multidisciplinary collaboration in providing access to the best in head and neck oncologic services. Let me give a couple of frequently encountered examples. Patients with laryngeal lesions involving the anterior commissure and those with impaired mobility staged T2 are often offered single-modality therapy with either surgery or irradiation. The result in terms of the voice quality is less predictable. The literature . . . [Full Text of this Article]

AUTHOR INFORMATION

Author Affiliations: Department of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, Pa.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?